Products You May Like
Ongoing efforts to develop a vaccine for COVID-19 have highlighted a number of intricate political and ethical questions for policymakers: How should governments balance commitments to developing a vaccine in comparison to capacity to test, trace and isolate? Is ‘vaccine nationalism’ a threat to fair distribution of the vaccine and, if so, who should the global community prioritise if a vaccine is developed? What are the implications of vaccine development on pharmaceutical business models?
Join Chelsea Clinton, Vice Chair of the Clinton Foundation; John-Arne Røttingen, Chief Executive of the Research Council of Norway and Visiting Fellow of Practice (2019–20) at the Blavatnik School of Government; Soumya Swavinatham, Chief Scientist at the World Health Organization; and Rajeev Venkayya, President of the Global Vaccine Business Unit at Takeda Pharmaceutical Company, to discuss the issues around vaccine development and delivery. The discussion will be moderated by Maya Tudor, Associate Professor of Government and Public Policy at the Blavatnik School of Government.
Blavatnik School of Government,
University of Oxford
http://www.bsg.ox.ac.uk/